1507 related articles for article (PubMed ID: 16207572)
21. Transjugular intrahepatic portosystemic shunt in the management of ascites and hepatorenal syndrome.
Senzolo M; Cholongitas E; Tibballs J; Burroughs A; Patch D
Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1143-50. PubMed ID: 17033432
[TBL] [Abstract][Full Text] [Related]
22. Management of ascites in the patient with portal hypertension with emphasis on spontaneous bacterial peritonitis.
Navasa M; Rodés J
Semin Gastrointest Dis; 1997 Oct; 8(4):200-9. PubMed ID: 9360284
[TBL] [Abstract][Full Text] [Related]
23. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.
European Association for the Study of the Liver
J Hepatol; 2010 Sep; 53(3):397-417. PubMed ID: 20633946
[No Abstract] [Full Text] [Related]
24. [Transjugular intrahepatic portosystemic stent-shunts or paracentesis in the treatment of cirrhotic patients with refractory ascites].
Ainsworth MA; Nielsen OH
Ugeskr Laeger; 2005 Aug; 167(35):3273-6. PubMed ID: 16138966
[No Abstract] [Full Text] [Related]
25. Cirrhotic ascites: pathogenesis and management.
Garcia-Tsao G
Gastroenterologist; 1995 Mar; 3(1):41-54. PubMed ID: 7743121
[TBL] [Abstract][Full Text] [Related]
26. TIPS versus paracentesis for the treatment of refractory ascites.
Lau A; Bay C; Nadir A
Hepatology; 2004 Dec; 40(6):1476; author reply 1476-7. PubMed ID: 15565609
[No Abstract] [Full Text] [Related]
27. Cirrhosis and Portal Hypertension: How Do We Deal with Ascites and Its Consequences.
Tonon M; Piano S
Med Clin North Am; 2023 May; 107(3):505-516. PubMed ID: 37001950
[TBL] [Abstract][Full Text] [Related]
28. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.
Wong W; Liu P; Blendis L; Wong F
Am J Med; 1999 Mar; 106(3):315-22. PubMed ID: 10190381
[TBL] [Abstract][Full Text] [Related]
29. Management of refractory ascites.
Singhal S; Baikati KK; Jabbour II; Anand S
Am J Ther; 2012 Mar; 19(2):121-32. PubMed ID: 21192246
[TBL] [Abstract][Full Text] [Related]
30. Pathophysiology, diagnosis and treatment of ascites in cirrhosis.
Arroyo V
Ann Hepatol; 2002; 1(2):72-9. PubMed ID: 15115971
[TBL] [Abstract][Full Text] [Related]
31. [Management of ascitis in patients with cirrhosis].
Arfaoui D; Ajmi S
Tunis Med; 2007 Feb; 85(2):91-5. PubMed ID: 17665651
[TBL] [Abstract][Full Text] [Related]
32. [TIPS is a life-prolonging treatment of those cirrhosis patients with ascites who can not be treated medically or with paracentesis].
Aalykke C; Tønner-Nielsen D; Vilstrup H
Ugeskr Laeger; 2005 Oct; 167(44):4197; author reply 4198-9. PubMed ID: 16266584
[No Abstract] [Full Text] [Related]
33. [New therapeutic paradigm and concepts for patients with cirrhotic refractory ascites].
Wang SZ; Ding HG
Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):249-253. PubMed ID: 28494541
[TBL] [Abstract][Full Text] [Related]
34. Large-volume paracentesis: a fast, convenient, and safe technique.
Banimahd F; Spinello IM
J Emerg Med; 2009 Nov; 37(4):409-10. PubMed ID: 19168313
[TBL] [Abstract][Full Text] [Related]
35. Fluid and electrolyte management of ascites in patients with cirrhosis.
Bass M
Crit Care Nurs Clin North Am; 1998 Dec; 10(4):459-67. PubMed ID: 10326425
[TBL] [Abstract][Full Text] [Related]
36. An update on the pathogenesis and clinical management of cirrhosis with refractory ascites.
Neong SF; Adebayo D; Wong F
Expert Rev Gastroenterol Hepatol; 2019 Apr; 13(4):293-305. PubMed ID: 30791777
[TBL] [Abstract][Full Text] [Related]
37. Portal hypertension.
Garcia-Tsao G
Curr Opin Gastroenterol; 2006 May; 22(3):254-62. PubMed ID: 16550040
[TBL] [Abstract][Full Text] [Related]
38. A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites.
Albillos A; Bañares R; González M; Catalina MV; Molinero LM
J Hepatol; 2005 Dec; 43(6):990-6. PubMed ID: 16139922
[TBL] [Abstract][Full Text] [Related]
39. Practical recommendations for the treatment of ascites and its complications.
Bataller R; Ginès P; Arroyo V
Drugs; 1997 Oct; 54(4):571-80. PubMed ID: 9339961
[TBL] [Abstract][Full Text] [Related]
40. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.
Gentilini P; Laffi G; La Villa G; Raggi VC
Ann Ital Med Int; 1999; 14(4):264-84. PubMed ID: 10638019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
